The vast majority of GBM arise de novo and harbor frequent mutations in 3 “core” signaling pathways: RB, TP53, and receptor tyrosine kinase (RTK)/mitogen activated protein kinase (MAPK)/phosphoinositide 3-kinase (PI3K) [5]. This evidence concerns the gene PIK3CA and glioblastoma.